The impact of therapy on the risk of asthma in type 2 diabetes
ConclusionsT2DM may have a protective effect against asthma development. Insulin use was associated with an increased risk of asthma, whilst metformin and sulphonylureas reduced the risk in those with T2DM.This article is protected by copyright. All rights reserved.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Louise H. Rayner,
Andrew P Mcgovern,
Julian Sherlock,
Piers Gatenby,
Ana Correa,
Ben Creagh ‐Brown,
Simon De Lusignan Tags: Original Article Source Type: research
More News: Asthma | Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | Metformin | Primary Care | Respiratory Medicine | Smokers | Study